Iowa’s facing a cancer crisis—with the fastest-rising and second-highest cancer rates in the nation, projected to hit over 21,000 new cases and 6,000 deaths this year. To combat it head-on, the University of Iowa is launching CANDID, a bold new institute designed to accelerate cancer drug discovery from lab to patient. By uniting scattered research talent, bringing in AI and clinical pharmacology experts, and securing $5.5 million in initial funding, CANDID aims to turn breakthroughs into life-saving treatments—and build a future-ready workforce to keep pushing the frontiers of cancer science.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
This is an automated, high-level news summary based on public reporting.
Sources:
https://www.thegazette.com/news/university-of-iowa-launching-new-cancer-drug-discovery-institute/article_2766976c-1c3e-4686-bf59-695c16d840d6.html
More coverage & latest updates:
https://sources.thednn.ai/9509a63d72bc5125